Aazim Siddiqui
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,743 | 97 | 67.1% |
| Travel and Lodging | $2,323 | 7 | 32.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bausch & Lomb Americas Inc. | $2,474 | 23 | $0 (2024) |
| BIOTISSUE HOLDINGS, INC. | $1,138 | 5 | $0 (2023) |
| ABBVIE INC. | $803.43 | 17 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $561.11 | 16 | $0 (2024) |
| Horizon Therapeutics plc | $347.74 | 4 | $0 (2023) |
| NEW WORLD MEDICAL,INC. | $302.24 | 4 | $0 (2024) |
| Amgen Inc. | $217.25 | 3 | $0 (2024) |
| Carl Zeiss Meditec USA, Inc. | $190.36 | 1 | $0 (2024) |
| Tarsus Pharmaceuticals, Inc. | $179.52 | 5 | $0 (2024) |
| Glaukos Corporation | $177.02 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,290 | 63 | Bausch & Lomb Americas Inc. ($2,337) |
| 2023 | $2,764 | 40 | BIOTISSUE HOLDINGS, INC. ($1,138) |
| 2021 | $13.05 | 1 | Glaukos Corporation ($13.05) |
All Payment Transactions
104 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $7.93 | General |
| Category: EYE CARE | ||||||
| 12/06/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $1.37 | General |
| Category: Ophthalmology | ||||||
| 12/03/2024 | NEW WORLD MEDICAL,INC. | Kahook Dual Blade (Device), Clearpath, Ahmed Glaucoma Valve | Food and Beverage | In-kind items and services | $4.93 | General |
| Category: Ophthalmology | ||||||
| 11/26/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $29.05 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/19/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $38.21 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 11/06/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $36.80 | General |
| Category: Ophthalmology | ||||||
| 11/06/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $25.94 | General |
| Category: Ophthalmology | ||||||
| 09/17/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: SOLUTION/ DROPS | ||||||
| 09/15/2024 | Bausch & Lomb Americas Inc. | IC-8 Apthera IOL (Device) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Ophthalmology | ||||||
| 09/06/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $28.97 | General |
| Category: OPTOMETRY | ||||||
| 08/23/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/21/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $29.88 | General |
| Category: EYE CARE | ||||||
| 08/13/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Ophthalmology | ||||||
| 08/08/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $6.63 | General |
| Category: Ophthalmology | ||||||
| 08/06/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug), Ryzumvi | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Dry eyes | ||||||
| 07/25/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: EYE CARE | ||||||
| 07/20/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: Ophthalmology | ||||||
| 07/18/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $28.63 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 07/16/2024 | Alcon Vision LLC | NGENUITY (Device) | Food and Beverage | In-kind items and services | $34.05 | General |
| Category: Ophthalmology | ||||||
| 07/09/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $42.34 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 06/18/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $28.15 | General |
| Category: OPTOMETRY | ||||||
| 06/09/2024 | Bausch & Lomb Americas Inc. | enVista Aspire IOL (Device), TENEO | Travel and Lodging | In-kind items and services | $96.55 | General |
| Category: Ophthalmology | ||||||
| 06/09/2024 | Bausch & Lomb Americas Inc. | enVista Aspire IOL (Device), TENEO | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: Ophthalmology | ||||||
| 06/08/2024 | Bausch & Lomb Americas Inc. | enVista Aspire IOL (Device), TENEO | Food and Beverage | In-kind items and services | $119.24 | General |
| Category: Ophthalmology | ||||||
| 06/08/2024 | Bausch & Lomb Americas Inc. | enVista Aspire IOL (Device), TENEO | Food and Beverage | In-kind items and services | $63.87 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 2,315 | 3,364 | $991,995 | $329,726 |
| 2022 | 3 | 64 | 103 | $18,745 | $9,709 |
| 2021 | 1 | 28 | 56 | $4,480 | $3,573 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 112 | 167 | $400,800 | $73,023 | 18.2% |
| J7351 | Injection, bimatoprost, intracameral implant, 1 microgram | Office | 2023 | 16 | 240 | $60,000 | $36,398 | 60.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 158 | 234 | $37,440 | $25,492 | 68.1% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 63 | 84 | $63,000 | $25,068 | 39.8% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 188 | 193 | $29,915 | $21,012 | 70.2% |
| 83861 | Microfluid analysis of tears | Office | 2023 | 383 | 893 | $44,650 | $19,673 | 44.1% |
| 65756 | Transplantation of outer layer of corneal tissue | Facility | 2023 | 15 | 18 | $54,000 | $18,843 | 34.9% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2023 | 22 | 27 | $66,150 | $17,181 | 26.0% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 128 | 128 | $25,600 | $16,393 | 64.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 179 | 219 | $25,185 | $16,144 | 64.1% |
| 65855 | Laser repair to improve eye fluid flow | Office | 2023 | 32 | 52 | $39,000 | $10,982 | 28.2% |
| 92250 | Photography of the retina | Office | 2023 | 269 | 276 | $31,740 | $8,812 | 27.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 59 | 59 | $11,800 | $6,842 | 58.0% |
| 68761 | Closure of tear duct opening using plug | Office | 2023 | 35 | 37 | $16,200 | $6,824 | 42.1% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 121 | 139 | $28,425 | $4,931 | 17.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 47 | 47 | $6,580 | $3,885 | 59.0% |
| 66030 | Injection of medication into eye | Office | 2023 | 16 | 23 | $6,900 | $3,668 | 53.2% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 58 | 59 | $7,080 | $3,139 | 44.3% |
| 92134 | Imaging of retina | Office | 2023 | 77 | 85 | $8,500 | $3,040 | 35.8% |
| 92133 | Imaging of optic nerve | Office | 2023 | 68 | 73 | $7,300 | $2,091 | 28.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 39 | 40 | $3,000 | $1,804 | 60.1% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 47 | 48 | $2,880 | $1,080 | 37.5% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 101 | 114 | $5,700 | $1,049 | 18.4% |
| 92025 | Ct scan of cornea | Office | 2023 | 26 | 29 | $1,450 | $872.89 | 60.2% |
| 92286 | Imaging of front third of eye using a special microscope | Office | 2023 | 12 | 13 | $3,900 | $449.49 | 11.5% |
About Aazim Siddiqui
Aazim Siddiqui is a Student in an Organized Health Care Education/Training Program healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2016. The National Provider Identifier (NPI) number assigned to this provider is 1770947723.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Aazim Siddiqui has received a total of $7,067 in payments from pharmaceutical and medical device companies, with $4,290 received in 2024. These payments were reported across 104 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($4,743).
As a Medicare-enrolled provider, Siddiqui has provided services to 2,407 Medicare beneficiaries, totaling 3,523 services with total Medicare billing of $343,009. Data is available for 3 years (2021–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Ophthalmology
- Location Portland, OR
- Active Since 04/06/2016
- Last Updated 06/05/2021
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1770947723
Products in Payments
- enVista Aspire IOL (Device) $2,213
- DURYSTA (Drug) $740.48
- Cequa (Drug) $561.11
- TEPEZZA (Drug) $347.74
- TEPEZZA (Biological) $217.25
- PROKERA (Device) $193.42
- EQ Workplace (Device) $190.36
- XDEMVY (Drug) $179.52
- RXSIGHT CONTACT LENS (Device) $163.19
- TYRVAYA (Drug) $110.52
- NGENUITY (Device) $81.13
- XIIDRA (Drug) $72.21
- HYDRUS Microstent (Device) $70.98
- OMNI SURGICAL SYSTEM (Device) $69.80
- VEVYE (Drug) $57.12
- OXERVATE (Drug) $53.80
- LUMIGAN (Drug) $50.39
- MIEBO (Drug) $37.75
- Omidria (Drug) $27.25
- EYSUVIS (Drug) $24.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Portland
Amanda Vansandt, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $280,593
Mathew Geltzeiler, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $186,613
Josha Woodward
Student in an Organized Health Care Education/Training Program — Payments: $99,642
Dr. Julie Graff, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $60,054
Trevor Crafts, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $50,126
Adel Kardosh, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $40,266